Clinical Trials · NCT01266213
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Samsung Medical Center
- Enrollment
- 147
- Start date
- Dec 2010
- Locations
- 1 site, South Korea
- Primary endpoint
- Time to Progression (TTP)